NASDAQ: SPPI

Spectrum Pharmaceuticals, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) between December 6, 2021 and September 22, 2022, both dates inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court no later than February 3, 2023.

If you purchased Spectrum Pharmaceuticals securities and would like to join the prospective action, please click “Join This Class Action.”

Class Period:December 6, 2021 to September 22, 2022

Deadline:

4 Days
If you purchased Spectrum Pharmaceuticals securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of the case:

The complaint alleges that, throughout the Class Period, defendants made numerous materially false and misleading statements and/or omissions concerning its drug candidate poziotinib, or “pozi”. Defendants were conducting a Phase 2 clinical trial called ZENITH20. The ZENITH20 trial was an ongoing, multicenter, multi-cohort, open-label, activity estimating study evaluating the anti-tumor effects, safety, and tolerability of pozi in patients with locally advanced or metastatic non-small cell lung cancer that were previously treated. Additionally, the complaint alleges that during the Class Period, Defendants represented that the safety and efficacy data from the ZENITH20 trial were positive and, based on those positive results, had initiated a required confirmatory phase 3 study. This, however, was not true.

When the truth entered the market over several days, the lawsuit alleges that investors suffered serious losses.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Follow us on:
Company Name: Spectrum Pharmaceuticals, Inc.
Stock Symbol: SPPI
Class Period: December 6, 2021 to September 22, 2022
Court: Southern District of New York

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top